TE_85
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | HERVFH19 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | SLC2A5 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 2.36 |
| Counts of samples | TCGA_tumor:131; TCGA_normal:0; GTEx:62 |
| TSS | chr1(-):9094185 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_85.1 | SLC2A5 | Chimeric | Non-coding | Non-coding | chr1(-):9047714,9047734,9057448,9057608,9058152,9058250,9069504,9069594,9085014,9085142,9094163,9094186 |
| teRNA_85.2 | SLC2A5 | Chimeric | Non-coding | Non-coding | chr1(-):9041917,9041937,9047610,9047734,9057448,9057608,9058152,9058250,9069504,9069594,9085014,9085166,9094163,9094186 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
